{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:36:51Z","timestamp":1740166611583,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Dr. August Wolff GmbH & Ko. KG Arzneimittel"},{"DOI":"10.13039\/501100012320","name":"Otto-von-Guericke-Universit\u00e4t Magdeburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012320","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hyperhidrosis is a chronic skin condition that impairs the patient\u2019s quality of life (QoL). There are several patient-reported outcome measures (PROMs) for patients affected by hyperhidrosis available; however an evidence-based assessment of their quality has not been undertaken so far.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>In our systematic review, we aim to identify all existing PROMs that were developed and\/or validated for measuring patient-reported outcomes in patients with hyperhidrosis and assess their measurement properties in a transparent and structured way to give a recommendation for future clinical research.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods\/design<\/jats:title>\n                <jats:p>Our systematic review aims to contain all PROMs developed and\/or validated for patients with hyperhidrosis. We will perform a highly sensitive, systematic literature search including the databases MEDLINE (Ovid), EMBASE (Ovid), and Science Citation Index Expanded and Social Sciences Citation Index (Web of Science). Especially studies which evaluate, describe, or compare measurement properties of PROMs for patients with hyperhidrosis will be considered as eligible. Two independent reviewers will judge the eligibility of the studies found in the literature search. The study and PROM characteristics will be summarized in evidence tables. The methodological quality of each study will be assessed using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) Risk of Bias checklist. We will apply predefined and consensus-based quality criteria for good measurement properties. Subsequently, the quality of the evidence will be graded. Furthermore, aspects on interpretability and feasibility will be described. A final recommendation will be given.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>In our systematic review, we aim to provide a comprehensive description of the quality of all existing PROMs for patients with hyperhidrosis. The assessment of measurement properties, interpretability, and feasibility will serve as a guidance regarding the selection of PROMs for future clinical hyperhidrosis trials.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Systematic review registration<\/jats:title>\n                <jats:p>PROSPERO CRD42020170247<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13643-021-01701-w","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T07:03:56Z","timestamp":1622617436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Measurement properties of patient-reported outcome measures (PROMs) in patients with hyperhidrosis: protocol for a systematic review"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1672-7549","authenticated-orcid":false,"given":"Michaela","family":"Gabes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helge","family":"Kn\u00fcttel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian J.","family":"Apfelbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,2]]},"reference":[{"issue":"9","key":"1701_CR1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1080\/14740338.2017.1354983","volume":"16","author":"C Hosp","year":"2017","unstructured":"Hosp C, Hamm H. Safety of available and emerging drug therapies for hyperhidrosis. Expert Opin Drug Saf. 2017;16(9):1039\u201349. https:\/\/doi.org\/10.1080\/14740338.2017.1354983.","journal-title":"Expert Opin Drug Saf."},{"key":"1701_CR2","doi-asserted-by":"publisher","unstructured":"Doolittle J, Walker P, Mills T, Thurston J. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res. 2016;308(10):743\u20139. https:\/\/doi.org\/10.1007\/s00403-016-1697-9.","DOI":"10.1007\/s00403-016-1697-9"},{"issue":"2","key":"1701_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jaad.2003.12.040","volume":"51","author":"DR Strutton","year":"2004","unstructured":"Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol. 2004;51(2):241\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2003.12.040.","journal-title":"J Am Acad Dermatol."},{"issue":"1","key":"1701_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jaad.2018.07.002","volume":"80","author":"DA Glaser","year":"2019","unstructured":"Glaser DA, Hebert AA, Nast A, Werschler WP, Green L, Mamelok R, et al. Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials. J Am Acad Dermatol. 2019;80(1):128\u201338 e2.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1701_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12955-017-0693-x","volume":"15","author":"P Kamudoni","year":"2017","unstructured":"Kamudoni P, Mueller B, Halford J, Schouveller A, Stacey B, Salek MS. The impact of hyperhidrosis on patients' daily life and quality of life: a qualitative investigation. Health Qual Life Outcomes. 2017;15(1):121. https:\/\/doi.org\/10.1186\/s12955-017-0693-x.","journal-title":"Health Qual Life Outcomes."},{"issue":"5","key":"1701_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1365-2753.2006.00650.x","volume":"12","author":"S Marshall","year":"2006","unstructured":"Marshall S, Haywood K, Fitzpatrick R. Impact of patient-reported outcome measures on routine practice: a structured review. J Eval Clin Pract. 2006;12(5):559\u201368. https:\/\/doi.org\/10.1111\/j.1365-2753.2006.00650.x.","journal-title":"J Eval Clin Pract."},{"issue":"23 Suppl","key":"1701_CR7","first-page":"S491","volume":"24","author":"M Lenefsky","year":"2018","unstructured":"Lenefsky M, Rice ZP. Hyperhidrosis and its impact on those living with it. Am J Manag Care. 2018;24(23 Suppl):S491\u2013S5.","journal-title":"Am J Manag Care."},{"issue":"3","key":"1701_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/09546634.2018.1506080","volume":"30","author":"R Wade","year":"2019","unstructured":"Wade R, Jones-Diette J, Wright K, Layton AM, Woolacott N. Hyperhidrosis quality of life measures: review and patient perspective. J Dermatolog Treat. 2019;30(3):303\u20138. https:\/\/doi.org\/10.1080\/09546634.2018.1506080.","journal-title":"J Dermatolog Treat."},{"issue":"4","key":"1701_CR9","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s11136-014-0825-2","volume":"24","author":"P Kamudoni","year":"2015","unstructured":"Kamudoni P, Mueller B, Salek MS. The development and validation of a disease-specific quality of life measure in hyperhidrosis: the Hyperhidrosis Quality of Life Index (HidroQOL(c)). Qual Life Res. 2015;24(4):1017\u201327. https:\/\/doi.org\/10.1007\/s11136-014-0825-2.","journal-title":"Qual Life Res."},{"key":"1701_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jclinepi.2017.12.020","volume":"96","author":"S Dodd","year":"2018","unstructured":"Dodd S, Clarke M, Becker L, Mavergames C, Fish R, Williamson PR. A taxonomy has been developed for outcomes in medical research to help improve knowledge discovery. J Clin Epidemiol. 2018;96:84\u201392. https:\/\/doi.org\/10.1016\/j.jclinepi.2017.12.020.","journal-title":"J Clin Epidemiol."},{"key":"1701_CR11","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"350","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647.","journal-title":"BMJ."},{"key":"1701_CR12","doi-asserted-by":"crossref","unstructured":"Mokkink LB, Prinsen CA, Patrick DL, Alonso J, Bouter LM, De Vet HC, et al. COSMIN methodology for systematic reviews of Patient-Reported Outcome Measures (PROMs) - user manual. 2018 Available at: https:\/\/www.cosmin.nl\/tools\/guideline-conducting-systematic-review-outcome-measures\/.","DOI":"10.1007\/s11136-018-1798-3"},{"issue":"5","key":"1701_CR13","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s11136-018-1798-3","volume":"27","author":"CAC Prinsen","year":"2018","unstructured":"Prinsen CAC, Mokkink LB, Bouter LM, Alonso J, Patrick DL, de Vet HCW, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1147\u201357. https:\/\/doi.org\/10.1007\/s11136-018-1798-3.","journal-title":"Qual Life Res."},{"key":"1701_CR14","unstructured":"Vissers T, Vries Rd. Quality of life (QoL) search blocks 2018 [updated 28.02.2018. Available from: https:\/\/blocks.bmi-online.nl\/catalog\/294."},{"key":"1701_CR15","unstructured":"Jansma EP, Vries Rd. Patient reported outcome measures (PROMs) search blocks 2017 [updated 21.04.2017. Available from: https:\/\/blocks.bmi-online.nl\/catalog\/248."},{"key":"1701_CR16","unstructured":"Mackintosh A, i Comabella CC, Hadi M, Gibbons E, Fitzpatrick R, Roberts N. PROM group construct & instrument type filters 2010 [Available from: http:\/\/www.cosmin.nl\/images\/upload\/files\/PROM%20Gp%20filtersOCTOBER%202010FINAL.pdf."},{"issue":"4","key":"1701_CR17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.socscimed.2004.06.022","volume":"60","author":"J Greenhalgh","year":"2005","unstructured":"Greenhalgh J, Long AF, Flynn R. The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? Soc Sci Med. 2005;60(4):833\u201343. https:\/\/doi.org\/10.1016\/j.socscimed.2004.06.022.","journal-title":"Soc Sci Med."},{"issue":"8","key":"1701_CR18","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s11136-009-9528-5","volume":"18","author":"CB Terwee","year":"2009","unstructured":"Terwee CB, Jansma EP, Riphagen II, de Vet HCW. Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments. Qual Life Res. 2009;18(8):1115\u201323. https:\/\/doi.org\/10.1007\/s11136-009-9528-5.","journal-title":"Qual Life Res."},{"key":"1701_CR19","unstructured":"Canada AU. Search filter for finding studies on measurement properties for OVID (Medline) 2015 2. Available from: http:\/\/www.cosmin.nl\/images\/upload\/files\/Translated%20search%20filter%20for%20measurement%20properties%20for%20OVID.pdf."},{"issue":"1","key":"1701_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13643-016-0202-z","volume":"5","author":"D Heinl","year":"2016","unstructured":"Heinl D, Prinsen CA, Drucker AM, Ofenloch R, Humphreys R, Sach T, et al. Measurement properties of quality of life measurement instruments for infants, children and adolescents with eczema: protocol for a systematic review. Syst Rev. 2016;5(1):25. https:\/\/doi.org\/10.1186\/s13643-016-0202-z.","journal-title":"Syst Rev."},{"key":"1701_CR21","doi-asserted-by":"publisher","unstructured":"Mokkink LB, de Vet HCW, Prinsen CAC, Patrick DL, Alonso J, Bouter LM, et al. COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures. Qual Life Res. 2018;27(5):1171\u20139. https:\/\/doi.org\/10.1007\/s11136-017-1765-4.","DOI":"10.1007\/s11136-017-1765-4"},{"issue":"7","key":"1701_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","volume":"63","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737\u201345. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.02.006.","journal-title":"J Clin Epidemiol."},{"issue":"1","key":"1701_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","volume":"60","author":"CB Terwee","year":"2007","unstructured":"Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34\u201342. https:\/\/doi.org\/10.1016\/j.jclinepi.2006.03.012.","journal-title":"J Clin Epidemiol."},{"issue":"1","key":"1701_CR24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s13063-016-1555-2","volume":"17","author":"CA Prinsen","year":"2016","unstructured":"Prinsen CA, Vohra S, Rose MR, Boers M, Tugwell P, Clarke M, et al. How to select outcome measurement instruments for outcomes included in a \"Core Outcome Set\" - a practical guideline. Trials. 2016;17(1):449. https:\/\/doi.org\/10.1186\/s13063-016-1555-2.","journal-title":"Trials."},{"issue":"7650","key":"1701_CR25","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD.","journal-title":"BMJ."},{"key":"1701_CR26","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511996214","volume-title":"Measurement in medicine","author":"HC De Vet","year":"2011","unstructured":"De Vet HC, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine. New York: Cambridge University Press; 2011. https:\/\/doi.org\/10.1017\/CBO9780511996214."}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-021-01701-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-021-01701-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-021-01701-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T07:07:14Z","timestamp":1622617634000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-021-01701-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1701"],"URL":"https:\/\/doi.org\/10.1186\/s13643-021-01701-w","relation":{},"ISSN":["2046-4053"],"issn-type":[{"type":"electronic","value":"2046-4053"}],"subject":[],"published":{"date-parts":[[2021,6,2]]},"assertion":[{"value":"20 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Christian Apfelbacher has received institutional funding from Dr. August Wolff GmbH & Co. KG Arzneimittel, and consultancy fees from Dr. August Wolff GmbH & Co. KG Arzneimittel and Sanofi Genzyme. He is a member of the executive committee of the Harmonising Outcome Measures for Eczema (HOME) initiative.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"163"}}